Paper36908673
Off-Label Use vs Off-Label Marketing of Drugs: Part 1: Off-Label Use-Patient Harms and Prescriber Responsibilities.
Van Norman GA. JACC Basic Transl Sci, 2023. Cited by 43 papers, by iCite.
Cite this record
ConductScience Library. Off-Label Use vs Off-Label Marketing of Drugs: Part 1: Off-Label Use-Patient Harms and Prescriber Responsibilities. Papers, record 36908673. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36908673
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Off-Label Use vs Off-Label Marketing of Drugs: Part 1: Off-Label Use-Patient Harms and Prescriber Responsibilities.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References56
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33887238 | Drug development research in pregnant and lactating women. | Am J Obstet Gynecol | 2021 | https://conductscience.org/library/papers/33887238 | PubMed |
| 2 | 27639184 | Students and Doctors are Unaware of the Cost of Drugs they Frequently Prescribe. | Basic Clin Pharmacol Toxicol | 2017 | https://conductscience.org/library/papers/27639184 | PubMed |
| 3 | 27159336 | Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts. | JAMA Intern Med | 2016 | https://conductscience.org/library/papers/27159336 | PubMed |
| 4 | 30422300 | Increasing the Participation of Pregnant Women in Clinical Trials. | JAMA | 2018 | https://conductscience.org/library/papers/30422300 | PubMed |
| 5 | 29069085 | Influence of pharmaceutical marketing on Medicare prescriptions in the District of Columbia. | PLoS One | 2017 | https://conductscience.org/library/papers/29069085 | PubMed |
| 6 | 22318929 | Assessment of prescribers' knowledge of the cost of medications. | Ann Pharmacother | 2012 | https://conductscience.org/library/papers/22318929 | PubMed |
| 7 | 9271479 | Valvular heart disease associated with fenfluramine-phentermine. | N Engl J Med | 1997 | https://conductscience.org/library/papers/9271479 | PubMed |
| 8 | 7641153 | Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks. | CMAJ | 1995 | https://conductscience.org/library/papers/7641153 | PubMed |
| 9 | 21047223 | Safety of recombinant activated factor VII in randomized clinical trials. | N Engl J Med | 2010 | https://conductscience.org/library/papers/21047223 | PubMed |
| 10 | 21291293 | "Under the radar": nurse practitioner prescribers and pharmaceutical industry promotions. | Am J Manag Care | 2010 | https://conductscience.org/library/papers/21291293 | PubMed |
| 11 | 16042137 | [The attitude of physicians regarding the promotion strategies of the pharmaceutical industry]. | Medicina (B Aires) | 2005 | https://conductscience.org/library/papers/16042137 | PubMed |
| 12 | 11025790 | Physicians' attitudes about prescribing and knowledge of the costs of common medications. | Arch Intern Med | 2000 | https://conductscience.org/library/papers/11025790 | PubMed |
| 13 | 33234538 | The Law and Practice of Off-Label Prescribing and Physician Promotion. | J Am Acad Psychiatry Law | 2021 | https://conductscience.org/library/papers/33234538 | PubMed |
| 14 | 34979147 | Anatomical suitability and off-label use of contemporary transcatheter heart valves. | Int J Cardiol | 2022 | https://conductscience.org/library/papers/34979147 | PubMed |
| 15 | 32599009 | Off-label use of pulmonary vasodilators after left ventricular assist device implantation: Calling in the evidence. | Pharmacol Ther | 2020 | https://conductscience.org/library/papers/32599009 | PubMed |
| 16 | 1347786 | Choosing between apples and apples: physicians' choices of prescription drugs that have similar side effects and efficacies. | J Gen Intern Med | 1992 | https://conductscience.org/library/papers/1347786 | PubMed |
| 17 | 34145575 | Benefit-Risk Assessment of Off-Label Drug Use in Children: The Bravo Framework. | Clin Pharmacol Ther | 2021 | https://conductscience.org/library/papers/34145575 | PubMed |
| 18 | 11742785 | Unlicensed and off-label drug use in elderly people. | Age Ageing | 2001 | https://conductscience.org/library/papers/11742785 | PubMed |
| 19 | 31082820 | Evaluating Physician Knowledge of Commonly Prescribed Inpatient Rehabilitation Unit Discharge Medication's Costs: An Observational Study. | Am J Phys Med Rehabil | 2020 | https://conductscience.org/library/papers/31082820 | PubMed |
| 20 | 17460228 | A national survey of physician-industry relationships. | N Engl J Med | 2007 | https://conductscience.org/library/papers/17460228 | PubMed |
Cited by32
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42627757 | Panitumumab-Based EGFR Blockade in SMARCB1-Deficient Renal Medullary Carcinoma: Preclinical Basis and Prospective Clinical Activity. | Clin Cancer Res | 2026 | https://conductscience.org/library/papers/42627757 | PubMed |
| 42325314 | Approaches to ketamine-assisted couple therapy. | Front Psychol | 2026 | https://conductscience.org/library/papers/42325314 | PubMed |
| 42277932 | Genetically supported drug target prioritization for rare diseases. | Genome Med | 2026 | https://conductscience.org/library/papers/42277932 | PubMed |
| 42244165 | Micro Doses, Macro Potential? Considerations for Microdosing Tirzepatide in Multi-Dose Pens. | Obesity (Silver Spring) | 2026 | https://conductscience.org/library/papers/42244165 | PubMed |
| 42058920 | Off-label and repurposed use of disulfiram beyond alcohol dependence: A systematic review of clinical and preclinical evidence. | iScience | 2026 | https://conductscience.org/library/papers/42058920 | PubMed |
| 42024289 | Signal Detection Using Change Point Analysis to Identify Safety Signals from Spontaneous Reports in Aortic Stent Grafts in Japan. | J Med Syst | 2026 | https://conductscience.org/library/papers/42024289 | PubMed |
| 41766233 | A prospective observational study on the off-label use of medications in the psychiatry outpatient department of a tertiary care hospital. | Indian J Pharmacol | 2026 | https://conductscience.org/library/papers/41766233 | PubMed |
| 41609931 | Prescription Depressant-Involved Overdose Mortality in Massachusetts (2000-2023): A Cohort Study. | J Gen Intern Med | 2026 | https://conductscience.org/library/papers/41609931 | PubMed |
| 41501776 | Prevalence of use and interest in using glucagon-like peptide-1 receptor agonists for weight loss: a population study in Great Britain. | BMC Med | 2026 | https://conductscience.org/library/papers/41501776 | PubMed |
| 41385096 | Medicines, Diseases, Indications, and Contraindications (MeDIC): a foundational resource to support drug repurposing. | Nucleic Acids Res | 2026 | https://conductscience.org/library/papers/41385096 | PubMed |
| 41306128 | Mapping the therapeutic versatility of WHO essential medicines: a systematic analysis of off-label indications. | Ther Adv Drug Saf | 2025 | https://conductscience.org/library/papers/41306128 | PubMed |
| 41295704 | Drug Repurposing in Veterinary Oncology: Myth or Reality? | Vet Sci | 2025 | https://conductscience.org/library/papers/41295704 | PubMed |
| 41172996 | Identification of therapeutic targets for renal medullary carcinoma via integrated genomic and transcriptomic profiling. | Cell Rep Med | 2025 | https://conductscience.org/library/papers/41172996 | PubMed |
| 41164765 | Off-label use catalogue of tumor anti-angiogenic drugs in China: a narrative review. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41164765 | PubMed |
| 41136597 | Development of tenecteplase for stroke thrombolysis: Japan's endeavor. | Hypertens Res | 2026 | https://conductscience.org/library/papers/41136597 | PubMed |
| 41070513 | Off-label Prescribing of Clozapine and Safety. | Turk Psikiyatri Derg | 2025 | https://conductscience.org/library/papers/41070513 | PubMed |
| 40869188 | The Expanding Role of Omalizumab: From Food Allergy to Drug Desensitization. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40869188 | PubMed |
| 40710367 | Therapeutic Potential of Calcium Channel Blockers in Neuropsychiatric, Endocrine and Pain Disorders. | Cells | 2025 | https://conductscience.org/library/papers/40710367 | PubMed |
| 40584250 | Clinical Outcomes of Implantable Collamer Lenses for the Treatment of Myopia in Eyes with Anterior Chamber Depth (<3.0 mm) at a Single Center in the United States. | Clin Ophthalmol | 2025 | https://conductscience.org/library/papers/40584250 | PubMed |
| 40497597 | Utilization of Ciprofloxacin-Dexamethasone in the Airway: A Scoping Review. | Laryngoscope | 2025 | https://conductscience.org/library/papers/40497597 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36908673
GET https://conductscience.org/api/papers/v1/36908673/references?page=2